A number of medical disorders can be diagnosed and treated with nuclear imaging, a type of medical imaging that uses trace amounts of radioactive materials, also referred to as radiotracers or radiopharmaceuticals. Nuclear imaging focuses on the physiological processes that occur within the body, as opposed to standard imaging techniques like MRIs and X-rays, which are primarily used to visualize anatomical structures. This method gives medical experts a crucial new way to look at diseases including cancer, heart disease, and neurological disorders by observing the way organs and tissues work and metabolic processes. Single-photon emission computed tomography (SPECT), gamma camera imaging, and positron emission tomography (PET) scans are typical nuclear imaging technologies.
Middle East and Africa Nuclear Imaging Market Driving Factors and Challenges
Drivers: One of the main factors propelling the market's expansion is the rising incidence of heart conditions and cancer. Cardiovascular and cancer disorders can be effectively treated with nuclear medicine. A number of variables, including an aging population, poor diet, smoking, and physical inactivity, are contributing to an increased cancer burden. Nuclear medicine imaging has significantly aided in cancer patients' diagnosis, treatment planning, and evaluation of response to treatment since the introduction of modern technology, and this is anticipated to fuel demand for it over the projected period.
Challenges: A significant challenge is the restricted accessibility and availability of nuclear imaging facilities and technology throughout the region. There is a dearth of nuclear imaging equipment and qualified workers in this region because many of the countries have relatively poor healthcare infrastructures. Nuclear imaging facility construction and operation may also be hampered by bureaucratic procedures and regulatory obstacles. Financial considerations are particularly important, since they have an impact on how affordable nuclear imaging treatments are for patients as well as how expensive imaging equipment can be purchased.
Impact of COVID-19 on Middle East and Africa Nuclear Imaging Market
Because social distancing measures were implemented by the governments in the region, which resulted in a severe drop in hospital and healthcare facilities, the COVID-19 pandemic had a detrimental effect on the Nuclear Imaging Market. In addition to having major worldwide economic repercussions, this interfered with the regular running of general hospital treatment for patients who were not COVID-19 patients. Notwithstanding these difficulties, oncological PET investigations shown a relatively lesser decrease in utilization when compared to standard nuclear medicine testing, according to a June 2022 Seminar in Nuclear Medicine report. In 2020, the pandemic considerably decreased the amount of nuclear medicine treatments conducted in the Middle East because to issues with the supply chain.
Middle East and Africa Nuclear Imaging Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players are; Bracco Imaging SpA, Canon Medical Systems Corporation, Cardinal Health Inc., Curium, Fujifilm Corporation, GE Healthcare, Koninklijke Philips NV, Mediso Ltd, NTP Radioisotopes SOC Ltd, Siemens AG
Middle East and Africa Nuclear Imaging Market Segmentation:
By Product: Based on the Product, Middle East and Africa Nuclear Imaging Market is segmented as; Equipment, Radioisotope.
By Application: Based on the Application, Middle East and Africa Nuclear Imaging Market is segmented as; SPECT Applications, PET Applications.
By Region: This research also includes data for GCC, South Africa, Rest of Middle East and Africa
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.